Telerehabilitation in COVID-19 Survivors

NCT ID: NCT05074979

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-27

Study Completion Date

2022-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was carried out in the post-acute period of the telerehabilitation program in individuals with dyspnea who had COVID-19; It will be done to examine the effects on dyspnea, exercise capacity, respiratory functions, activities of daily living, muscle strength, muscle oxygenation, fatigue and quality of life parameters.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Telerehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

While other groups continue their exercise program for 6 weeks, this group will only be informed after COVID 19.

Group Type OTHER

informed program

Intervention Type OTHER

will informed after COVID 19

home exercise program group

this group will implement COVID 19 home exercise program.

Group Type EXPERIMENTAL

home exercise program

Intervention Type OTHER

While telerehabilitation sessions will be applied to the participants in the telerehabilitation group for 6 weeks, home exercise program will be given to the home exercise program group and will be applied for 6 weeks.

telerehabilitation group

this group will implement COVID 19 telerehabilitation program.

Group Type EXPERIMENTAL

telerehabilitation

Intervention Type OTHER

While telerehabilitation sessions will be applied to the participants in the telerehabilitation group for 6 weeks, home exercise program will be given to the home exercise program group and will be applied for 6 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

telerehabilitation

While telerehabilitation sessions will be applied to the participants in the telerehabilitation group for 6 weeks, home exercise program will be given to the home exercise program group and will be applied for 6 weeks.

Intervention Type OTHER

home exercise program

While telerehabilitation sessions will be applied to the participants in the telerehabilitation group for 6 weeks, home exercise program will be given to the home exercise program group and will be applied for 6 weeks.

Intervention Type OTHER

informed program

will informed after COVID 19

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with COVID-19 by Computed Tomography (CT) or PCR test between the ages of 18-75,
* Do not have any orthopedic or neurological disease that will affect exercise capacity,
* Individuals who can take and execute verbal orders,
* Have had COVID-19 and at least 2 weeks have passed since the completion of the treatment,
* Individuals who have a computer or smart phone with a camera and internet connection and have the ability to use it (the participant himself or one of his family members living in the same house),
* Individuals who are sedentary (those whose physical activity level is inactive according to the Turkish version of the International Physical Activity Questionnaire (UFAA)),
* Having dyspnea at level 2 or 3 on the Medical Research Council Dyspnea Scale.

Exclusion Criteria

* Those who have not had COVID-19 or acute period patients who are experiencing COVID-19,
* Individuals who cannot be contacted,
* Individuals with chronic heart disease,
* Those with concomitant uncontrolled disease; uncontrolled hypertension (resting blood pressure ≥160 /100mmHg), uncontrolled diabetes (random instantaneous blood glucose\>16.7 mmol/l, HbA1C\>7.0%),
* Those with concomitant severe organic disease (unstable hemodynamic heart disease, heart failure causing movement limitation, unstable angina, MI or other cardiac disease in the last 12 years),
* Individuals with cerebrovascular disease in the last 6 months,
* Those with digestive system ulcer, thyroid dysfunction or active stage of tuberculosis,
* Patients with Chronic Kidney Failure stage 3 and above according to Glomerular Filtration Rate (GFR),
* Individuals who have undergone intraraticular medication or surgery from their lower extremities in the last 6 months,
* Individuals who cannot walk independently,
* Individuals with any mental illness that may prevent them from living independently or receiving treatment,
* Uncooperative individuals for assessment and rehabilitation programs,
* Those with alcohol or substance addiction,
* Those who are pregnant, suspected of pregnancy or considering becoming pregnant,
* Participants in another study within the last 3 months or currently.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bandırma Onyedi Eylül University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Canan Demir

Research Assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bandırma Onyedi Eylül University, Faculty of Health Sciences, Physiotherapy and Rehabilitation Department

Balıkesir, Bandırma, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CDemir

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Telerehabilitation in COPD
NCT05053061 RECRUITING NA